Later, miR-206 (Wang Y. et al., 2019) and miR-23b (Salvi et al., 2009) were found to attenuate cell viability, migration, and invasion by blocking the c-Met activation in HCC. This evidence concerns the gene MET and hepatocellular carcinoma.